1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Freenome completed its business combination with PCSC, and the filing details the post-closing arrangements. Approximately 65,440,613 shares, about 60.9% of New Freenome common stock, are subject to registration rights, and Sponsor and certain former Freenome stockholders are restricted from transferring shares for six months after closing. Shareholders should note the potential for future resales and the new equity plans, which add shares available for issuance.
Amendment No. 1, dated July 20, 2026, reduced New Freenome's board from nine to seven directors following the Closing.
Under the Investor Rights Agreement, New Freenome must file a resale registration statement within 30 calendar days after the Closing Date.
Lock-up agreements bar transfers, with certain permitted exceptions, until six months after the Closing Date.
The 2026 Equity Incentive Plan initially reserves 14,773,227 shares, and the 2026 Employee Stock Purchase Plan initially reserves 2,462,204 shares.
Valvoline's board elected two new non-employee directors, Katherine Fogertey and Scott Mezvinsky, effective July 22, 2026. The filing describes their compensation and committee assignments, and it reports no related-party transactions that require disclosure.
Fogertey joins the Audit Committee and Mezvinsky joins the Governance & Nominating Committee.
Each director receives a $100,000 annual cash retainer and a pro-rated equity award with a grant date value of $70,644, granted July 22, 2026.
The restricted stock units fully vest on July 22, 2027, subject to continued board service.
QXO filed a prospectus supplement covering resale by certain selling stockholders of 41,405,099 common shares issuable on conversion of Series C preferred stock, plus 96,267 shares of that preferred stock. The filing satisfies QXO's registration obligations under a January 5, 2026 Investment Agreement, and it does not state any proceeds to the company.
Resale covers 41,405,099 common shares issuable on conversion of Series C Convertible Perpetual Preferred Stock
Also covers 96,267 shares of Series C preferred stock
Filed July 23, 2026 under Form S-3ASR registration statement first filed July 29, 2024
Filed to meet obligations under the Investment Agreement dated January 5, 2026
Victory Capital Holdings announced that director Dominique Carrel-Billiard resigned from its Board effective July 23, 2026, citing his departure from Amundi, and that Nicolas Calcoen, Deputy Chief Executive Officer of Amundi, was appointed to the Board the same day. The filing says the resignation was not due to any disagreement with the company, and Mr. Calcoen waived director compensation, so the change is a board membership update with no reported financial figures.
Carrel-Billiard notified the Board on July 22, 2026 of his intent to resign effective July 23, 2026, due to leaving Amundi; the filing states no disagreement with the company.
Nicolas Calcoen joined the Board effective July 23, 2026 as a Class III director, with a term expiring at the 2027 Annual Meeting of Stockholders.
Calcoen waived compensation for his non-employee director service and received an indemnification agreement like other directors.
The company reported $346.1 billion in total client assets as of June 30, 2026, per the press release boilerplate.
Meridian Corp disclosed that Andy Fox, Senior Vice President and Chief Credit Officer, separated from the company on July 21, 2026, to pursue other opportunities. Geoff Sheehan, Senior Vice President of Credit Administration, will assume the Chief Credit Officer role, which oversees the bank's credit function. The filing does not describe any financial impact or the reasons beyond the stated departure.
Andy Fox, Senior Vice President and Chief Credit Officer, separated from the company on July 21, 2026
Fox left to pursue other opportunities, per the filing
Geoff Sheehan, Senior Vice President, Credit Administration, will assume the Chief Credit Officer role
The filing was signed by CFO Denise Lindsay on July 21, 2026
Paymentus Holdings director Adam Malinowski resigned effective July 23, 2026, and the board elected Gregory Williams the same day to fill the vacancy. Williams is a Managing Director at Accel-KKR, the private equity firm that nominated Malinowski, and was appointed under that firm's nomination rights in the company's stockholders agreement. The filing reports no financial figures and says Williams is not expected to receive cash retainer fees or equity awards.
Adam Malinowski notified the board on July 22, 2026 of his resignation as director, effective July 23, 2026; the filing says it was not due to any disagreement with the company.
Gregory Williams was elected on July 23, 2026 as a Class II director with a term expiring at the 2029 Annual Meeting of Stockholders; the board determined he meets NYSE independence requirements.
Williams has been a Managing Director at Accel-KKR since July 2009 and is not expected to be appointed to any board committee.
The appointment follows nomination rights under the Stockholders Agreement dated May 24, 2021, which is filed as an exhibit to the February 24, 2026 Form 10-K.
Enerpac Tool Group appointed Kevin J. Hagen as Principal Accounting Officer and Vice President and Global Controller on July 23, 2026. The company also told Patrick J. Dawson he will no longer serve as Principal Accounting Officer and Corporate Controller on the same day. The filing is an administrative change to the company's senior accounting leadership and includes no financial results.
Kevin J. Hagen, age 46, appointed Principal Accounting Officer and Vice President and Global Controller on July 23, 2026
Hagen joined Enerpac in June 2026 as Vice President of Finance and previously held accounting roles at The Sherwin-Williams Company
Patrick J. Dawson notified on July 23, 2026 that he will no longer serve as Principal Accounting Officer and Corporate Controller
At its annual meeting on July 23, 2026, Uranium Energy Corp. stockholders elected all six director nominees, ratified PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending July 31, 2026, and approved the non-binding advisory vote on executive compensation. The company also reported that its board re-appointed Amir Adnani as President and CEO and Josephine Man as CFO, Treasurer and Secretary, which is routine for shareholders as the votes confirm the current board and management structure.
Quorum: 360,697,854 shares, about 72.9% of the 494,872,366 shares outstanding as of the May 29, 2026 record date, were present in person or by proxy.
Directors: all six nominees were elected, including Amir Adnani with 284,913,462 votes for and 21,324,498 withheld.
Auditor: PricewaterhouseCoopers LLP was ratified with 357,342,477 votes for and 2,895,792 against.
Say-on-pay: executive compensation was approved with 299,936,455 votes for, 5,059,182 against and 1,242,323 abstentions.
Delek US Holdings, Inc. said its Board of Directors approved a quarterly dividend of $0.255 per share. The dividend is payable August 10, 2026, to shareholders of record on August 3, 2026, so holders on that record date will receive the payment.
Quarterly dividend of $0.255 per share approved by the Board
Western Union said its Executive Vice President and Chief Legal Officer, Benjamin Adams, will leave his post under the company's Voluntary Retirement Program, effective November 2, 2026. He will keep overseeing legal, privacy, public policy and enterprise risk during the notice period while helping transition his duties until a successor is appointed.
Adams notified the company of his retirement on July 20, 2026; departure is effective November 2, 2026.
Successor not yet named; Adams will assist with the transition until one is appointed.
Under the program, he is entitled to six months of base salary, a prorated 2026 target annual incentive award, and continued vesting of equity awards.
InterPrivate Investment Partners V, Inc., a blank check company, announced that holders of its IPO units may elect to separately trade Class A ordinary shares and warrants starting on or about July 27, 2026. The change affects how existing unit holders can trade their securities and does not alter the terms of the warrants, which carry an $11.50 exercise price per share.
Separate trading of Class A ordinary shares and warrants begins on or about Monday, July 27, 2026.
Separated shares and warrants will trade on Nasdaq under IPVV and IPVVW; unseparated units continue under IPVVU.
Each unit holds one Class A ordinary share and one-third of one warrant; each whole warrant exercises at $11.50 per share.
Holders must have their brokers contact Continental Stock Transfer & Trust Company to separate units.
ImageneBio appointed Yanina Grant-Huerta as Chief Financial Officer effective July 20, 2026, replacing CEO Kristin Yarema, who had been serving as interim principal financial officer. Separately, Chief Medical Officer Benjamin Porter-Brown will move from a full-time role to a consulting role effective July 24, 2026.
Grant-Huerta receives a $450,000 annual base salary and a 40% target discretionary bonus, plus a 65,000-share RSU grant and a 95,000-share stock option grant.
Her severance terms include 12 months of base salary and continued group health benefits for up to 12 months, with enhanced change-in-control benefits.
Grant-Huerta previously served as Chief Accounting Officer at Atara Biotherapeutics from March 2025 to July 2026 and spent 14 years at Amgen before that.
Dr. Porter-Brown will continue as a consulting clinical development expert and strategic advisor.
Codexis said on July 23, 2026 that it expects second-quarter 2026 revenue of at least $14.8 million and cash, cash equivalents and short-term investments of about $54.9 million as of June 30, 2026. The figures are preliminary, unaudited and subject to the company's financial closing procedures, so the final results may differ.
Preliminary total revenue for the three months ended June 30, 2026 is at least $14.8 million.
Preliminary cash, cash equivalents and short-term investments as of June 30, 2026 are about $54.9 million.
The auditor has not reviewed these preliminary figures, and the company says final results may vary.
Albemarle's board appointed Eduardo De Salles Bartolomeo as an independent director effective July 21, 2026, and named him to the Audit & Finance Committee and the Safety, Sustainability, Operations & Capital Committee. The filing says he previously served as CEO of Vale S.A. from 2019 to 2024, and it discloses his director compensation, but it contains no financial results or guidance.
Appointed as an independent director effective July 21, 2026, announced in a July 23, 2026 press release
Previously served as Chief Executive Officer of Vale S.A. from 2019 to 2024, according to the press release
Annual director retainer of $120,000, paid quarterly and pro-rated for the partial year, plus restricted stock grant valued at $170,000 at grant date, also pro-rated
Filing states no arrangement with any person under which he was selected and no related-party transactions requiring disclosure
Southern Cross Acquisition I Corp., a blank check company listed on Nasdaq under the ticker NCO, closed its initial public offering of 11,500,000 units at $10.00 per unit on July 22, 2026, for gross proceeds of $115,000,000, including the full exercise of the underwriters' over-allotment option. The company placed $115,000,000 in a trust account, which will not be released until a business combination is completed, shareholders redeem shares in certain circumstances, or the company fails to complete a business combination within 12 months of the IPO.
11,500,000 units sold at $10.00 per unit, for gross proceeds of $115,000,000, including 1,500,000 over-allotment units
Private sale of 239,300 units to the sponsor for $2,393,000, completed concurrently with the IPO closing
$115,000,000 placed in trust; funds are generally held until a business combination, or are returned if none is completed within 12 months of the IPO
Directors Zhiqiang Du, Zhuo Liang and Qian Xu became directors effective July 21, 2026; Ally Tong Zhang is chief executive officer
On July 23, 2026, JPMorgan Chase & Co. closed public offerings of four note series totaling $9.0 billion, comprising $6.0 billion of senior notes and $3.0 billion of subordinated notes. The notes were registered under a Form S-3 shelf registration, and the filing adds legal opinions on their legality, so the filing reports a financing event rather than a change in operating results.
Floating Rate Notes due 2030: $500 million aggregate principal amount
Southern California Edison and its SCE Recovery Funding LLC entered into an underwriting agreement on July 21, 2026 for $1,953,948,000 of Senior Secured Recovery Bonds, Series 2026-A, with the bonds expected to be dated July 28, 2026. The filing is a debt financing document; it does not report earnings or change guidance, and the filing does not state the use of proceeds beyond the issuance itself.
Underwriting agreement dated July 21, 2026 with RBC Capital Markets, Barclays Capital, Citigroup Global Markets and J.P. Morgan Securities as representatives
Bond principal of $1,953,948,000 under the Series 2026-A offering, issued by SCE Recovery Funding LLC
Bonds offered under a prospectus dated July 2, 2026; indenture, servicing and related agreements to be dated July 28, 2026
Archer-Daniels-Midland appointed Jeffrey Rowe, currently CEO of Syngenta Group, as Executive Vice President and Chief Operating Officer, effective August 17, 2026. He will oversee ADM's commercial businesses, global manufacturing and R&D, reporting to Chair and CEO Juan Luciano, and his offer letter includes a $1,200,000 base salary and sizable one-time make-whole awards.
Rowe steps down as Syngenta Group CEO effective August 1, 2026, a role he has held since January 2024.
Offer letter sets a $1,200,000 base salary, a 175% target annual cash incentive, and an annual target equity award of $12,500,000.
One-time make-whole awards total $18,890,000: a $2,200,000 cash bonus payable January 2027 and RSUs with a $16,690,000 grant date value.
The position is newly created, and Rowe reports to Juan Luciano.
On July 23, 2026, Virtu Financial's subsidiaries signed Amendment No. 4 to their credit agreement, issuing $500 million of incremental senior secured first lien term B-2 loans. The total term B-2 loan balance is $2,029.55 million, and the company said the proceeds will be used for general corporate purposes. The filing adds to the company's debt, and it does not state how the loans will affect earnings.
Incremental term B-2 loans of $500 million were issued on July 23, 2026, with the total term B-2 balance at $2,029.55 million.
The loans mature on June 21, 2031, and amortize in annual installments of about 1.0% of the incremental principal.
Interest is set at either term SOFR plus 2.50%, or a base rate option plus 1.50%, at the borrower's election.
Per the press release, the loans were issued at par and the proceeds may be used for general corporate purposes.
Cingulate's Board decided on July 17, 2026 to eliminate the Chief Legal Officer position, and Nilay Patel will leave as an officer effective August 3, 2026. The company said the departure is a termination without cause under his existing employment agreement and that it does not plan to hire a replacement.
Board decision to eliminate the Chief Legal Officer role made July 17, 2026
Nilay Patel's last day as an officer is August 3, 2026, described as termination without cause
No replacement planned for the Chief Legal Officer role
Coinbase said Chief People Officer Lawrence Brock will leave the role effective August 17, 2026, and the company expects to appoint Dominique Baillet as successor. Brock will then serve as an advisor from September 2 through November 30, 2026, under an agreement that includes a lump sum payment equal to three months of his base salary.
Lawrence Brock notified Coinbase on July 22, 2026 of his intention to step down as Chief People Officer, effective August 17, 2026.
Brock remains an employee through September 1, 2026 to assist with the transition.
Advisor Agreement signed July 23, 2026 covers services from September 2 through November 30, 2026.
Brock receives a lump sum equal to three months of current base salary after the advisory period, plus continued vesting of RSUs scheduled for November 20, 2026.
On July 17, 2026, EVI Industries and its subsidiaries signed three asset purchase agreements to acquire substantially all assets of Sudsies and related entities, with consideration of $22.6 million, $4.0 million and $900,000. The deals open EVI's consumer garment care services division, and management expects them to be accretive to earnings for the fiscal year ending June 30, 2027. Closing is expected within 30 to 45 days, subject to conditions, and either side may terminate if closing has not occurred by September 1, 2026.
Transaction A: $22.6 million consideration, with $1.716 million held in escrow for at least 12 months
Transaction B: $4.0 million consideration, with $232,000 held in escrow for at least 12 months
Transaction C: $900,000 consideration, including $800,000 in cash and $52,000 in escrow
Closing expected within 30 to 45 days; termination right if not closed by September 1, 2026
On July 17, 2026, FreeCast's board increased its size from three to four and appointed Eric Seidel as a director, effective immediately. Seidel was also named the second member of the audit committee, which helps the company move toward the three-member audit committee Nasdaq requires. The filing says the board considers him independent.
Board expanded from three to four directors, effective July 17, 2026, and Eric Seidel appointed to fill the new seat
Seidel is the second audit committee member; the company previously had one, and Nasdaq requires three
Board determined Seidel is independent under Rule 10A-3 and Nasdaq Rule 5605(a)(2)
Seidel, age 62, has been CEO of Kinloom since June 2025 and previously led Web-Est and eAutoclaims
On July 23, 2026, Axalta entered Amendment No. 2 to its merger agreement with AkzoNobel, changing governance terms for the combined company. The amendment sets annual re-election of all MergeCo directors after an initial three-year period and a two-thirds non-executive director approval threshold for specified matters during that period. The companies said the changes leave the August 5, 2026 AkzoNobel EGM and Axalta SGM on schedule, so shareholder votes are not affected by the amendment.
Annual re-election of all MergeCo directors after the initial three-year period; the press release says this was previously contemplated after five years.
Two-thirds non-executive director approval threshold during the initial three years for director appointments and dismissals, CEO, Deputy CEO and CFO changes, Chair and Vice Chair titles, and remuneration policy amendments; the press releas
AkzoNobel EGM and Axalta SGM planned for August 5, 2026 are proceeding with existing agenda items unaffected.
CS Disco's board increased its size from eight to nine and appointed Andre Mintz as an independent Class II director, effective immediately, with a term expiring at the 2029 annual meeting. Mintz brings a cybersecurity and privacy background, including his recent role as a Meta Platforms vice president before retiring in May 2026.
Board expanded from eight to nine directors on July 22, 2026; Andre Mintz appointed effective immediately
Mintz's Class II term expires at the 2029 annual meeting; the board deems him independent under NYSE rules
Initial equity award of RSUs valued at $300,000 vesting over 12 quarterly installments, plus a $35,000 annual cash retainer
Mintz also gets a $150,000 annual RSU award starting with the 2027 annual meeting, and enters the standard indemnification agreement
Effective July 21, 2026, the Compensation Committee granted one-time special retention equity awards to CEO Jennifer M. Johnson, Co-Presidents Daniel Gamba, Terrence J. Murphy and Matthew Nicholls, and carry incentive allocations to CEO Jennifer M. Johnson and Executive Chairman Gregory E. Johnson. The filing says the awards are meant to retain the core leadership team and that the carry incentives have no realizable value at grant, paying out only if fund performance exceeds pre-specified hurdles.
Each equity award has a grant-date fair value of approximately $15 million, split 50% performance stock units (fiscal years 2027 to 2029, payout range 0% to 187.5%) and 50% restricted stock units vesting August 31, 2031.
Carry incentives to the CEO and Executive Chairman vest over five years, with one-third eligible in years three, four and five.
The filing states the awards are not part of regular annual compensation; full award terms will be filed with the Form 10-K for the fiscal year ending September 30, 2026.
Canton Strategic Holdings, Inc. sold its biotech research subsidiary, Gravitas Life Sciences, LLC, to Gravitas Collective Corp., a buyer affiliated with three former directors, and the sale closed on July 17, 2026. The company received an unsecured $3.5 million promissory note plus contingent development milestone payments, and unaudited pro forma figures show smaller net losses had the sale occurred earlier.
Sold 100% of Gravitas Life Sciences, LLC, a clinical-stage biotech unit, to Gravitas Collective Corp.; the transaction closed July 17, 2026.
Consideration: unsecured promissory note of $3.5 million at 15% annual interest, paid in kind, maturing July 17, 2029, plus possible development milestone payments.
Buyer is affiliated with former directors Vincent LoPriore, Sireesh Appajosyula and Gary Stetz; an independent special committee reviewed the terms.
Unaudited pro forma net loss: $25.8 million for 2025 versus $35.9 million as reported; $45.5 million for Q1 2026 versus $47.3 million as reported.
Northrim BanCorp agreed on July 22, 2026 to acquire PBCO Financial Corporation, the holding company of Oregon-based People's Bank of Commerce, in an all-stock merger valued at approximately $167.3 million. PBCO shareholders would receive 1.160 Northrim shares for each PBCO share, and the deal is expected to close in the fourth quarter of 2026 or early in the first quarter of 2027, subject to shareholder and regulatory approvals. The filing also marks Northrim's first out-of-state expansion and would increase the combined company's assets to about $4.2 billion, with PBCO shareholders owning about 21.1% of the combined company.
Exchange ratio: 1.160 Northrim shares per PBCO share; aggregate value about $167.3 million, or $32.36 per PBCO share, based on Northrim's $27.90 close on July 21, 2026
PBCO had about $776.6 million in assets, $570.1 million in gross loans and $610.1 million in deposits as of June 30, 2026
Termination fee of $6,692,331 payable by PBCO to Northrim under specified circumstances
Expected closing in the fourth quarter of 2026 or early in the first quarter of 2027, subject to shareholder and regulatory approvals
Bone Biologics said it completed a July 2026 private placement with one healthcare-focused institutional investor, with gross proceeds of about $3.0 million before fees and expenses. The company says the financing extends its operating runway through Q2 2027, and the filing contains no revenue or earnings figures.
July 2026 private placement with a single healthcare-focused institutional investor, priced at-the-market under Nasdaq rules, for gross proceeds of about $3.0 million before fees and expenses
Series F and G warrants could add up to about $6.0 million if fully exercised for cash, but the company gives no assurance that any will be exercised
Company expects to complete patient enrollment in its first-in-human NB1 pilot study by year-end
Validated shelf life of rhNELL-1 extended to 29 months in May 2026, up from 24 months in December 2025
Albertsons Companies announced that President and Chief Financial Officer Sharon McCollam plans to retire later this year. She will stay in her role until a successor is named, then serve in an advisory capacity through fiscal year-end on February 27, 2027, to support the transition.
Sharon McCollam, President and CFO, plans to retire later in 2026
She remains in her role until a successor is named
Advisory role continues until the end of fiscal year on Feb. 27, 2027
The company is conducting a search for a new leader; no successor is named in the filing
United Therapeutics expanded its Board of Directors to 13 members and appointed Victor Dzau, M.D., effective July 22, 2026. Dr. Dzau will not initially serve on a board committee, and the company granted him director equity awards under its standard director compensation program.
Board size increased to 13 members; Dr. Dzau appointed July 22, 2026, with no initial committee assignment
Initial grant of 380 restricted stock units and 1,190 stock options, plus pro-rata grants of 350 RSUs and 1,110 options for the 2026-2027 board service year
Dr. Dzau previously served as President of the National Academy of Medicine for 12 years, with that term expiring in June 2026
Company describes the appointment as part of its ongoing board refreshment effort
CVB Financial Corp. appointed Michael J. Maddox as a director of the Company and its bank subsidiary, Citizens Business Bank, effective July 22, 2026. The filing says the appointment raises the size of each board from 10 to 11 directors, and Mr. Maddox will receive a $77,000 annual directors' fee plus a pro-rated restricted stock grant.
Maddox was previously CEO of CrossFirst Bankshares and later president and CEO of Busey Bank until January 2026.
Annual directors' fee of $77,000; initial restricted stock grant to be approved at an August 23, 2026 Compensation Committee meeting.
Both the Company and Bank boards expand from 10 to 11 directors, within their By-laws.
Maddox will sit on the Company's Audit, Nominating and Corporate Governance, and Compensation committees.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.